GB Patent

GB2570319B — A medicament delivery device

Assigned to Consort Medical Ltd · Expires 2021-01-06 · 5y expired

What this patent protects

Patent listed against chembl-chembl34259.

Drugs covered by this patent

chembl-chembl34259 (METHOTREXATE)

Patent Metadata

Patent number: GB2570319B
Jurisdiction: GB
Classification: —
Expires: 2021-01-06
Drug substance claim: No
Drug product claim: No
Assignee: Consort Medical Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.